House appoints its farm bill conference committee members primarily from Agriculture Committee but also with reps from committees with oversight for a variety of topics due to the breadth of the legislation and to contentious issues unrelated to including supplements as SNAP, or food stamp, benefits. Supplement industry also looks to fate of legislation that would allow using pre-tax health savings accounts to buy OTC drugs without having a doctor's prescription as a sign for whether VMS product purchases will be allowed with the accounts, as proposed in House and Senate bills.
A House and Senate conference committee will decide whether multivitamins will be included in Department of Agriculture Supplemental Nutrition Assistance Program benefits when they negotiate the latest farm bill to reauthorize USDA programs for another five years.
In addition to tracking the farm bill conference committee, the dietary supplement industry looks to the fate of legislation that...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
P&G's FY2024 Q4 net sales were flat at $20.5bn, lower than consensus estimates, but the firm says its underlying business divisions are healthy and forecasts FY2025 sales up 2% to 4%, up 3% to 5% organically.
Legislator education is key to checking state bills that overreach, says Ross, executive VP of government affairs at the Personal Care Products Council, discussing the rising tide of US state bills aimed at restricting ingredient use.
FDA reminds companies which registered with agency solely to manufacture OTC sanitizers during COVID-19 public health emergency they will be subject to FY2025 OTC monograph user fees if they don’t delist and deregister as monograph drug manufacturers by 12 a.m. on 31 December.
With monographs@FDA portal down, agency moves to NextGen and extends comment period through 27 September for first OTC monograph change it proposed using its overhauled program other than 32 monographs finalizations required in 2020 legislation authorizing overhaul.
OTC sales edged up at Italy's Recordati in the first half of 2024 as higher demand for GI products and supplements offset a weaker cold & flu season.
P&G's FY2024 Q4 net sales were flat at $20.5bn, lower than consensus estimates, but the firm says its underlying business divisions are healthy and forecasts FY2025 sales up 2% to 4%, up 3% to 5% organically.
